Alaunos Therapeutics (TCRT) Times Interest Earned (2021 - 2023)
Historic Times Interest Earned for Alaunos Therapeutics (TCRT) over the last 3 years, with Q2 2023 value amounting to -$7.47.
- Alaunos Therapeutics' Times Interest Earned rose 4009.97% to -$7.47 in Q2 2023 from the same period last year, while for Mar 2024 it was -$24.66, marking a year-over-year decrease of 13361.12%. This contributed to the annual value of -$17.84 for FY2023, which is 6260.34% down from last year.
- Latest data reveals that Alaunos Therapeutics reported Times Interest Earned of -$7.47 as of Q2 2023, which was up 4009.97% from -$10.75 recorded in Q1 2023.
- In the past 5 years, Alaunos Therapeutics' Times Interest Earned registered a high of -$7.47 during Q2 2023, and its lowest value of -$50.22 during Q3 2021.
- In the last 3 years, Alaunos Therapeutics' Times Interest Earned had a median value of -$11.61 in 2022 and averaged -$15.98.
- As far as peak fluctuations go, Alaunos Therapeutics' Times Interest Earned skyrocketed by 8043.18% in 2022, and later soared by 1719.68% in 2023.
- Over the past 3 years, Alaunos Therapeutics' Times Interest Earned (Quarter) stood at -$14.62 in 2021, then surged by 35.23% to -$9.47 in 2022, then increased by 21.06% to -$7.47 in 2023.
- Its last three reported values are -$7.47 in Q2 2023, -$10.75 for Q1 2023, and -$9.47 during Q4 2022.